Imatinib for Chronic Myeloid Leukemia: A Real-World Perspective
Abstract
Treatment with a tyrosine kinase inhibitor — imatinib, dasatinib, or nilotinib — is the standard of care for patients with newly...
Paper Details
Title
Imatinib for Chronic Myeloid Leukemia: A Real-World Perspective
Published Date
Apr 26, 2011
Journal
Volume
2011
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History